跳转至内容
Merck
CN

860799O

Avanti

CP-LC-0729

Avanti Research - A Croda Brand

别名:

2-hexyldecyl 3-((4-((2-(dimethylamino)ethyl)amino)-3-(2-hexyldecanamido)-4-oxobutyl)thio)propanoate

登录 查看组织和合同定价。

选择规格

变更视图

关于此项目

经验公式(希尔记法):
C43H85N3O4S
分子量:
740.22
NACRES:
NA.21
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


biological source

synthetic

assay

>99% (TLC)

form

powder

manufacturer/tradename

Avanti Research - A Croda Brand

packaging

pkg of pkg of 1 x 5 mg (860799O-5MG)

application(s)

advanced drug delivery

lipid type

transfection
cationic lipids

shipped in

dry ice

storage temp.

−20°C

General description

CP‑LC‑0729 is a next-generation ionizable lipid designed for efficient nucleic acid delivery using lipid nanoparticles (LNPs).

Application

advanced drug delivery

Features and Benefits

This cationic lipid demonstrates superior performance in vivo expression and tolerability, particularly for hepatic and pulmonary delivery applications. Formulations with CP-LC-0729 have a measured pKa of ~6.78 and promotes effective endosomal escape, an essential mechanism for successful mRNA, saRNA, or circRNA release into the cytosol. Its branched hydrophobic structure supports the formation of stable, homogenous LNPs with high encapsulation efficiency and low polydispersity.

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC


存储类别

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库